您的位置: 首页 > 农业专利 > 详情页

human anti-tau antibodies and tau binding fragment thereof, their use in the preparation of a medicament, as well as polypeptides encoding them.
专利权人:
BIOGEN INTERNATIONAL NEUROSCIENCE GMBH;BIOGEN MA INC.
发明人:
ELLEN A. GARBER,FABIO MONTRASIO,FENG CHEN,JAN GRIMM,PAUL H. WEINREB
申请号:
BR112015014751
公开号:
BR112015014751A8
申请日:
2013.12.20
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
abstract provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as thereto related methods. assays, kits, and solid supports related to specific antibodies for tau are also disclosed. the antibody, immunoglobulin chain (s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for targeted immunotherapy and diagnosis, respectively. abstract translation "human anti-tau antibodies". Novel human tau specific antibodies are provided, as well as fragments, derivatives and variants thereof, as well as methods related thereto. Assays, kits and solid supports related to tau specific antibodies are also disclosed. The antibody, immunoglobulin chain (s), as well as binding fragments, derivatives and variants thereof may be used in pharmaceutical and diagnostic compositions for tau-directed immunotherapy and diagnosis, respectively. 1/1abstract provided are novel human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. assays, kits, and solid supports related to antibodies specific for tau are also disclosed. the antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively. tradução do resumo resumo "anticorpos anti-tau humanos". são fornecidos novos anticorpos específicos de tau humanos, bem como fragmentos, derivados e variantes dos mesmos, bem como métodos relacionados aos mesmos. ensaios, kits e suportes sólidos relacionados aos anticorpos específicos para tau também são divulgados. o anticorpo, cadeia(s) de imunoglobulina, bem como fragmentos de ligação, derivados e variantes dos mesmos podem ser usados em composições farmacêuticas e diagnósticas para imunoterapia direcionada para tau e diagnóstico, respectivamente. 1/1
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充